Synthetic Biologics Inc (SYN) Rating Increased to Buy at Zacks Investment Research

Zacks Investment Research’s price target would suggest a potential ... cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is ...